Roche, Bristol-Myers cut cancer drug prices to win UK approval

LONDON, Nov 17 (Reuters) - Roche and Bristol-Myers

Squibb on Thursday became the latest drugmakers to cut

the price of cancer medicines in order to secure access to

Britain's National Health Service.

Read more